Patients Medical Professionals Careers Investors Media Therapy Sites Global Sites About Us Research & Pipeline Therapies Responsibility News & Insights Previous Next Transforming Neuroscience Our Company Focus on Patients Novel Science Caring Deeply Innovative therapies We develop medicines for debilitating medical conditions with the goal of making a meaningful difference in patients’ lives. More about our therapies FILTER BY All approved therapies Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis Hemophilia Hemophilia Partnered Therapies Partnered Therapies Biosimilars Biosimilars Dedicated to new discoveries Our pipeline is more than a list of medicines in development. It reflects the work we do here every day to break new ground with science that makes a difference in the lives of patients. Filter by: All disease areas All phases Phase 1 2 3 Filed Aducanumab (Aβ mAb) Alzheimer’s disease Nusinersen (IONIS-SMNRx) Spinal muscular atrophy (SMA) Obinutuzumab Front-line Indolent non-Hodgkin’s lymphoma Ocrelizumab Primary progressive and relapsing multiple sclerosis See full pipeline Caring deeply about those around us We understand that what we do matters ­— to our patients, our employees and the communities in which we live and work. See how Our perspectives August 23, 2016 Pursuing Science That Transforms Lives See all perspectives Building the next Biogen As we embark on building the Biogen of the future, we will focus on areas with the potential to have the most impact, developing life-changing treatments for people suffering from devastating conditions. Review our 2015 performance About Us About Biogen Executive Leadership Board of Directors History Manufacturing Biosimilars Positions & Policy Contact Us Governance Research & Pipeline Pipeline Clinical Trials Access to Investigational Therapies BiogenScience Meet Our Scientists Areas of Research Postdoc Program Collaborations Medical Research portal Therapies Multiple Sclerosis AVONEX® FAMPYRA® PLEGRIDY® TECFIDERA® TYSABRI® ZINBRYTA™ Hemophilia ALPROLIX® ELOCTATE® Partnered Therapies GAZYVA® RITUXAN® Biosimilars BENEPALI® FLIXABI® Responsibility Corporate Citizenship Supporting Patients Rethinking Resources Community & Foundation Acting Responsibly Humanitarian Aid Grants Office News & Insights Perspectives Latest Press Releases Events and Webcasts Patients Medical Professionals Careers Investors Media Follow us on: LinkedIn Twitter YouTube Privacy Policy Terms & Conditions Sitemap Forward-Looking Statements Community Guidelines Contact Us © 2016 Biogen